{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T00:20:47Z","timestamp":1793319647546,"version":"4.5.0"},"reference-count":39,"publisher":"Japanese Circulation Society","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Circ J"],"published-print":{"date-parts":[[2018]]},"DOI":"10.1253\/circj.cj-17-0419","type":"journal-article","created":{"date-parts":[[2017,8,31]],"date-time":"2017-08-31T18:18:14Z","timestamp":1504203494000},"page":"532-540","source":"Crossref","is-referenced-by-count":18,"title":["Effect of Intensive and Standard Pitavastatin Treatment With or Without Eicosapentaenoic Acid on Progression of Coronary Artery Calcification Over 12 Months\u3000\u2015 Prospective Multicenter Study \u2015"],"prefix":"10.1253","volume":"82","author":[{"given":"Toru","family":"Miyoshi","sequence":"first","affiliation":[{"name":"Department of Cardiovascular Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kunihisa","family":"Kohno","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirohiko","family":"Asonuma","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Kasaoka Daiichi Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoru","family":"Sakuragi","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Iwakuni Clinical Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makoto","family":"Nakahama","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Fukuyama City Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusuke","family":"Kawai","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Ehime Prefectural Center Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tadahisa","family":"Uesugi","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Sumitomo Besshi Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takefumi","family":"Oka","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Tsuyama Chuo Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitsuru","family":"Munemasa","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Okayama Clinical Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natsuki","family":"Takahashi","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Matsuyama Shimin Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoki","family":"Mukohara","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Himeji Red Cross Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seiji","family":"Habara","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Kurashiki Central Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasushi","family":"Koyama","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Sakurabashi Watanabe Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazufumi","family":"Nakamura","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Ito","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"on behalf of the PEACH Investigators","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"330","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Maahs DM, Snell-Bergeon JK, Kinney GL, Wadwa RP, Garg S, Ogden LG, et al. ACE-I\/ARB treatment in type 1 diabetes patients with albuminuria is associated with lower odds of progression of coronary artery calcification. <i>J Diabetes Complications<\/i> 2007; 21: 273\u2013279.","DOI":"10.1016\/j.jdiacomp.2006.04.004"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Madhavan MV, Tarigopula M, Mintz GS, Maehara A, Stone GW, Genereux P. Coronary artery calcification: Pathogenesis and prognostic implications. <i>J Am Coll Cardiol<\/i> 2014; 63: 1703\u20131714.","DOI":"10.1016\/j.jacc.2014.01.017"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Callister TQ, Raggi P, Cooil B, Lippolis NJ, Russo DJ. Effect of HMG-CoA reductase inhibitors on coronary artery disease as assessed by electron-beam computed tomography. <i>N Engl J Med<\/i> 1998; 339: 1972\u20131978.","DOI":"10.1056\/NEJM199812313392703"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Achenbach S, Ropers D, Pohle K, Leber A, Thilo C, Knez A, et al. Influence of lipid-lowering therapy on the progression of coronary artery calcification: A prospective evaluation. <i>Circulation<\/i> 2002; 106: 1077\u20131082.","DOI":"10.1161\/01.CIR.0000027567.49283.FF"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Budoff MJ, Lane KL, Bakhsheshi H, Mao S, Grassmann BO, Friedman BC, et al. Rates of progression of coronary calcium by electron beam tomography. <i>Am J Cardiol<\/i> 2000; 86: 8\u201311.","DOI":"10.1016\/S0002-9149(00)00820-1"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Hecht HS, Harman SM. Relation of aggressiveness of lipid-lowering treatment to changes in calcified plaque burden by electron beam tomography. <i>Am J Cardiol<\/i> 2003; 92: 334\u2013336.","DOI":"10.1016\/S0002-9149(03)00642-8"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Arad Y, Spadaro LA, Roth M, Newstein D, Guerci AD. Treatment of asymptomatic adults with elevated coronary calcium scores with atorvastatin, vitamin C, and vitamin E: The St. Francis Heart Study randomized clinical trial. <i>J Am Coll Cardiol<\/i> 2005; 46: 166\u2013172.","DOI":"10.1016\/j.jacc.2005.02.089"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Raggi P, Davidson M, Callister TQ, Welty FK, Bachmann GA, Hecht H, et al. Aggressive versus moderate lipid-lowering therapy in hypercholesterolemic postmenopausal women: Beyond Endorsed Lipid Lowering with EBT Scanning (BELLES). <i>Circulation<\/i> 2005; 112: 563\u2013571.","DOI":"10.1161\/CIRCULATIONAHA.104.512681"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Houslay ES, Cowell SJ, Prescott RJ, Reid J, Burton J, Northridge DB, et al. Progressive coronary calcification despite intensive lipid-lowering treatment: A randomised controlled trial. <i>Heart<\/i> 2006; 92: 1207\u20131212.","DOI":"10.1136\/hrt.2005.080929"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Schmermund A, Achenbach S, Budde T, Buziashvili Y, Forster A, Friedrich G, et al. Effect of intensive versus standard lipid-lowering treatment with atorvastatin on the progression of calcified coronary atherosclerosis over 12 months: A multicenter, randomized, double-blind trial. <i>Circulation<\/i> 2006; 113: 427\u2013437.","DOI":"10.1161\/CIRCULATIONAHA.105.568147"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Terry JG, Carr JJ, Kouba EO, Davis DH, Menon L, Bender K, et al. Effect of simvastatin (80 mg) on coronary and abdominal aortic arterial calcium (from the coronary artery calcification treatment with zocor [CATZ] study). <i>Am J Cardiol<\/i> 2007; 99: 1714\u20131717.","DOI":"10.1016\/j.amjcard.2007.01.060"},{"key":"12","unstructured":"12. Alagona P Jr. Pitavastatin: Evidence for its place in treatment of hypercholesterolemia. <i>Core Evid<\/i> 2010; 5: 91\u2013105."},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Teramoto T, Shimano H, Yokote K, Urashima M. Effects of pitavastatin (LIVALO tablet) on high density lipoprotein cholesterol (HDL-C) in hypercholesterolemia. <i>J Atheroscler Thromb<\/i> 2009; 16: 654\u2013661.","DOI":"10.5551\/jat.1719"},{"key":"14","unstructured":"14. Kimmig LM, Karalis DG. Do omega-3 polyunsaturated fatty acids prevent cardiovascular disease?: A review of the randomized clinical trials. <i>Lipid Insights<\/i> 2013; 6: 13\u201320."},{"key":"15","unstructured":"15. Serhan CN. Novel lipid mediators and resolution mechanisms in acute inflammation: To resolve or not? <i>Am J Pathol<\/i> 2010; 177: 1576\u20131591."},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Doi M, Nosaka K, Miyoshi T, Iwamoto M, Kajiya M, Okawa K, et al. Early eicosapentaenoic acid treatment after percutaneous coronary intervention reduces acute inflammatory responses and ventricular arrhythmias in patients with acute myocardial infarction: A randomized, controlled study. <i>Int J Cardiol<\/i> 2014; 176: 577\u2013582.","DOI":"10.1016\/j.ijcard.2014.08.055"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Agatston AS, Janowitz WR, Hildner FJ, Zusmer NR, Viamonte M Jr, Detrano R. Quantification of coronary artery calcium using ultrafast computed tomography. <i>J Am Coll Cardiol<\/i> 1990; 15: 827\u2013832.","DOI":"10.1016\/0735-1097(90)90282-T"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Callister TQ, Cooil B, Raya SP, Lippolis NJ, Russo DJ, Raggi P. Coronary artery disease: Improved reproducibility of calcium scoring with an electron-beam CT volumetric method. <i>Radiology<\/i> 1998; 208: 807\u2013814.","DOI":"10.1148\/radiology.208.3.9722864"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. American Diabetes Association. Standards of medical care in diabetes\u20132008. <i>Diabetes Care<\/i> 2008; 31(Suppl 1): S12\u2013S54.","DOI":"10.2337\/dc08-S012"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Gassett AJ, Sheppard L, McClelland RL, Olives C, Kronmal R, Blaha MJ, et al. Risk factors for long-term coronary artery calcium progression in the multi-ethnic study of atherosclerosis. <i>J Am Heart Assoc<\/i> 2015; 4: e001726.","DOI":"10.1161\/JAHA.114.001726"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Budoff MJ, Hokanson JE, Nasir K, Shaw LJ, Kinney GL, Chow D, et al. Progression of coronary artery calcium predicts all-cause mortality. <i>JACC Cardiovasc Imaging<\/i> 2010; 3: 1229\u20131236.","DOI":"10.1016\/j.jcmg.2010.08.018"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Kronmal RA, McClelland RL, Detrano R, Shea S, Lima JA, Cushman M, et al. Risk factors for the progression of coronary artery calcification in asymptomatic subjects: Results from the Multi-Ethnic Study of Atherosclerosis (MESA). <i>Circulation<\/i> 2007; 115: 2722\u20132730.","DOI":"10.1161\/CIRCULATIONAHA.106.674143"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Puri R, Nicholls SJ, Shao M, Kataoka Y, Uno K, Kapadia SR, et al. Impact of statins on serial coronary calcification during atheroma progression and regression. <i>J Am Coll Cardiol<\/i> 2015; 65: 1273\u20131282.","DOI":"10.1016\/j.jacc.2015.01.036"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Henein M, Granasen G, Wiklund U, Schmermund A, Guerci A, Erbel R, et al. High dose and long-term statin therapy accelerate coronary artery calcification. <i>Int J Cardiol<\/i> 2015; 184: 581\u2013586.","DOI":"10.1016\/j.ijcard.2015.02.072"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Zhao XQ, Yuan C, Hatsukami TS, Frechette EH, Kang XJ, Maravilla KR, et al. Effects of prolonged intensive lipid-lowering therapy on the characteristics of carotid atherosclerotic plaques in vivo by MRI: A case-control study. <i>Arterioscler Thromb Vasc Biol<\/i> 2001; 21: 1623\u20131629.","DOI":"10.1161\/hq1001.098463"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Urabe Y, Yamamoto H, Kitagawa T, Utsunomiya H, Tsushima H, Tatsugami F, et al. Association between serum levels of n-3 polyunsaturated fatty acids and coronary plaque detected by coronary computed tomography angiography in patients receiving statin therapy. <i>Circ J<\/i> 2013; 77: 2578\u20132585.","DOI":"10.1253\/circj.CJ-13-0257"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Calder PC. N-3 polyunsaturated fatty acids and inflammation: From molecular biology to the clinic. <i>Lipids<\/i> 2003; 38: 343\u2013352.","DOI":"10.1007\/s11745-003-1068-y"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Serhan CN, Clish CB, Brannon J, Colgan SP, Chiang N, Gronert K. Novel functional sets of lipid-derived mediators with antiinflammatory actions generated from omega-3 fatty acids via cyclooxygenase 2-nonsteroidal antiinflammatory drugs and transcellular processing. <i>J Exp Med<\/i> 2000; 192: 1197\u20131204.","DOI":"10.1084\/jem.192.8.1197"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Bannenberg GL, Chiang N, Ariel A, Arita M, Tjonahen E, Gotlinger KH, et al. Molecular circuits of resolution: Formation and actions of resolvins and protectins. <i>J Immunol<\/i> 2005; 174: 4345\u20134355.","DOI":"10.4049\/jimmunol.174.7.4345"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Arnold C, Markovic M, Blossey K, Wallukat G, Fischer R, Dechend R, et al. Arachidonic acid-metabolizing cytochrome P450 enzymes are targets of {omega}-3 fatty acids. <i>J Biol Chem<\/i> 2010; 285: 32720\u201332733.","DOI":"10.1074\/jbc.M110.118406"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Ueeda M, Doumei T, Takaya Y, Shinohata R, Katayama Y, Ohnishi N, et al. Serum N-3 polyunsaturated fatty acid levels correlate with the extent of coronary plaques and calcifications in patients with acute myocardial infarction. <i>Circ J<\/i> 2008; 72: 1836\u20131843.","DOI":"10.1253\/circj.CJ-08-0249"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Abedin M, Lim J, Tang TB, Park D, Demer LL, Tintut Y. N-3 fatty acids inhibit vascular calcification via the p38-mitogen-activated protein kinase and peroxisome proliferator-activated receptor-gamma pathways. <i>Circ Res<\/i> 2006; 98: 727\u2013729.","DOI":"10.1161\/01.RES.0000216009.68958.e6"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. Hiro T, Kimura T, Morimoto T, Miyauchi K, Nakagawa Y, Yamagishi M, et al. Effect of intensive statin therapy on regression of coronary atherosclerosis in patients with acute coronary syndrome: A multicenter randomized trial evaluated by volumetric intravascular ultrasound using pitavastatin versus atorvastatin (JAPAN-ACS [Japan assessment of pitavastatin and atorvastatin in acute coronary syndrome] study). <i>J Am Coll Cardiol<\/i> 2009; 54: 293\u2013302.","DOI":"10.1016\/j.jacc.2009.04.033"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34. Motoyama S, Sarai M, Harigaya H, Anno H, Inoue K, Hara T, et al. Computed tomographic angiography characteristics of atherosclerotic plaques subsequently resulting in acute coronary syndrome. <i>J Am Coll Cardiol<\/i> 2009; 54: 49\u201357.","DOI":"10.1016\/j.jacc.2009.02.068"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35. Budinski D, Arneson V, Hounslow N, Gratsiansky N. Pitavastatin compared with atorvastatin in primary hypercholesterolemia or combined dyslipidemia. <i>Clin Lipidol<\/i> 2009; 4: 291\u2013302.","DOI":"10.2217\/clp.09.20"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36. Sattar N, Preiss D, Murray HM, Welsh P, Buckley BM, de Craen AJ, et al. Statins and risk of incident diabetes: A collaborative meta-analysis of randomised statin trials. <i>Lancet<\/i> 2010; 375: 735\u2013742.","DOI":"10.1016\/S0140-6736(09)61965-6"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37. Huang CH, Huang YY, Hsu BR. Pitavastatin improves glycated hemoglobin in patients with poorly controlled type 2 diabetes. <i>J Diabetes Investig<\/i> 2016; 7: 769\u2013776.","DOI":"10.1111\/jdi.12483"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38. Thakker D, Nair S, Pagada A, Jamdade V, Malik A. Statin use and the risk of developing diabetes: A network meta-analysis. <i>Pharmacoepidemiol Drug Saf<\/i> 2016; 25: 1131\u20131149.","DOI":"10.1002\/pds.4020"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39. Barrios V, Escobar C. Clinical benefits of pitavastatin: Focus on patients with diabetes or at risk of developing diabetes. <i>Future Cardiol<\/i> 2016; 12: 449\u2013466.","DOI":"10.2217\/fca-2016-0018"}],"container-title":["Circulation Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/circj\/82\/2\/82_CJ-17-0419\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,2]],"date-time":"2019-10-02T20:51:33Z","timestamp":1570049493000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/circj\/82\/2\/82_CJ-17-0419\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018]]},"references-count":39,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.1253\/circj.cj-17-0419","relation":{},"ISSN":["1346-9843","1347-4820"],"issn-type":[{"value":"1346-9843","type":"print"},{"value":"1347-4820","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018]]}}}